DrugsControl Media Services

News Detail

Medtronic receives FDA approval for extravascular defibrillator to treat abnormal heart rhythms, sudden cardiac arrest (25-10-2023)

DUBLIN, 24 OCT  2023: Medtronic plc, a global leader in healthcare technology, has received U.S. Food and Drug Administration (FDA) approv......
View Details

Source : Medtronic plc
Heart Rhythm Electrophysiology Remote Monitoring Policy & Regulations Aurora EV-ICD™ MRI SureScan™

Related News